Clinical Trials Logo

Atrophy clinical trials

View clinical trials related to Atrophy.

Filter by:

NCT ID: NCT02766946 Completed - Septic Shock Clinical Trials

Diaphragmatic Atrophy Related to Mechanical Ventilation

ECHODIAPH
Start date: June 24, 2013
Phase: N/A
Study type: Interventional

Ventilatory support during critical phase result in inactivity of respiratory muscles especially diaphragm muscle. These inactivity also result in change of contractile capability and quick muscular atrophy. The aim of the study is to visualize the evolution of diaphragm thickness by echography during Mechanical Ventilation for patients with septic shock or acute respiratory distress syndrome and to compare with the evolution for patients under non-invasive ventilation and those with spontaneous ventilation. Measurements will be performed at day 1, day 5 and day 10 (if patient still under a mode of ventilation or in the unit). The evolution of diaphragm thickness will also be compared to pectoralis muscle atrophy, which is not involved in ventilation, in order to assess respective effect of ventilatory inactivity and undernutrition linked to intensive care.

NCT ID: NCT02761707 Completed - Parkinson's Disease Clinical Trials

Biomarkers in Neural Disorders

Start date: June 2016
Phase:
Study type: Observational

This study seeks to establish the sensitivity and specificity of what appears to be a unique brainstem biomarker of Parkinson's Disease (PD) - an electrically induced olygosynaptic nasotrigeminal reflex response - in differentiating early stage PD from normal controls and from patients with various other neurodegenerative diseases. This study will additionally compare the biomarker to olfactory testing.

NCT ID: NCT02751125 Completed - Bone Atrophy Clinical Trials

Reconstruction of Jaw Bone Using Mesenchymal Stem Cells

Start date: June 2014
Phase: Phase 1
Study type: Interventional

This pilot study is aimed to reconstruct atrophied posterior alveolar mandibular ridges using biomaterial and autologous bone marrow derived stem cells (BMMSC) and to insert an implant into the new bone in a prosthetically guided position.

NCT ID: NCT02747641 Completed - Vaginal Atrophy Clinical Trials

Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects

Start date: May 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the use of the Alma CO2 Pixel FemiLift™ in the treatment of VulvoVaginal Atrophy (VVA) in postmenopausal female subjects. The primary endpoint is to assess the change in the vaginal dryness by means of a Visual Analogic Scale (10 cm VAS) and/or Bachmann Index in VVA. The clinical improvement will be assessed by patient filled Vulvovaginal Atrophy.

NCT ID: NCT02735421 Completed - Acne Vulgaris Clinical Trials

Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars

OSCAR
Start date: May 13, 2016
Phase: Phase 4
Study type: Interventional

This was a multi-centre, randomized, investigator blinded, vehicle controlled trial using intra-individual comparison (right half-face versus left half-face). Participants with each half-face randomized to one of the two following treatments: - Adapalene 0.3 percent (%) - benzoyl peroxide (BPO) 2.5% gel (TactuPump® Forte). - Vehicle gel The main objective of this trial was to evaluate the effect of Adapalene 0.3% - BPO 2.5% (ABPO Forte) gel versus vehicle gel on the risk of formation of atrophic acne scars in moderate to severe acne participants.

NCT ID: NCT02724280 Completed - Gastritis Clinical Trials

Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

H. pylori infection plays a very important role in gastric carcinogenesis, progressing from chronic gastritis through atrophic gastritis, intestinal metaplasia, dysplasia and finally cancer. It is difficult to diagnose H. pylori related gastritis and gastric atrophy on the basis of endoscopic findings. Histology is currently considered to be the gold standard for detecting H. pylori infection. The reliability of detecting H. pylori infection histologically depends on the site, number, and size of gastric biopsy specimens. The blind biopsy sampling of normal appearing mucosa has the risk of missing pathology and sampling errors. Most studies conclude that as well as on expertise in staining and visualizing the bacteria. Considerable error also occurs in identifying gastric atrophy using blind biopsy sampling, and neither the original nor the revised version of the Sydney system reliably identifies more than half the cases in patients with confirmed gastric atrophy.

NCT ID: NCT02705755 Completed - Parkinson Disease Clinical Trials

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Start date: September 9, 2017
Phase: Phase 2
Study type: Interventional

This multiple-center, 3-part, single-blind dose escalation (Part A), randomized, double-blind (Part B), and open-label multiple dose extension (Part C) study will be conducted in male and female subjects with neurogenic orthostatic hypotension to evaluate the effect of TD-9855 in improving symptoms of orthostatic intolerance.

NCT ID: NCT02691936 Completed - Menopause Clinical Trials

Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy

VeLVET
Start date: March 2016
Phase: N/A
Study type: Interventional

This is a multi-centered, randomized prospective single blinded clinical trial comparing CO2 fractionated vaginal laser therapy and vaginal estrogen cream therapy in the treatment of vulvovaginal atrophy/GSM.

NCT ID: NCT02691637 Completed - Clinical trials for Helicobacter Pylori Infection

Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients

Start date: February 2006
Phase:
Study type: Observational

Helicobacter pylori (H. pylori) infection has been associated with a development of atrophic gastritis and intestinal metaplasia. H. pylori related atrophic gastritis and intestinal metaplasia have been regarded as pre-malignant lesion. However, the role of H. pylori eradication treatment in the reversibility of atrophic gastritis and intestinal metaplasia has not been clearly defined. The aim of the present study was to investigate the relationship between H. pylori eradication and the reversibility of atrophic gastritis and intestinal metaplasia in Korean patients.

NCT ID: NCT02686658 Completed - Clinical trials for Macular Degeneration

Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Start date: January 20, 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The objectives of this study were to evaluate the safety and efficacy of Zimura intravitreal (IVT) administration when administered in participants with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD).